Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Figure 2: Changes in A) SOD activity, B) total GSH, C) IL-6 levels in BALF, and D) TNF-alpha levels in BALF across the treatment groups in response to varying doses of GHK-Cu
Overall, BPC 157 ranks as moderately stable among research peptides
*Digestive Diseases and Sciences*, 42(12), 2420-2428
Semaglutide Component Properties Complete Specifications: Classification: GLP-1 receptor agonist Molecular Weight: 4,113 Da Molecular Formula: CHNO Structural Basis: Modified human GLP-1(7-37) with Aib8 and C18 fatty acid at K26 Key Modifications: Aminoisobutyric acid (Aib) at position 8, C18 fatty diacid at K26, linker modifications Primary Target: GLP-1 receptors (class B GPCR) Mechanism: GLP-1 receptor agonism with 94% albumin binding Plasma Half-Life: ~165 hours (~7 days), enabling once-weekly research administration CAS Number: 910463-68-2 Appearance: White to off-white lyophilized powder The semaglutide component provides long-acting GLP-1 receptor activation research capabilities
Strictly for institutional laboratory research and in vitro analysis only
Here are answers to the most common dosage and protocol concerns people have when starting BPC-157
US$ 25.22
US$ 27.60
US$ 29.15
US$ 21.69
US$ 26.02
US$ 29.38
US$ 21.26
